A 52-week efficacy and safety study of enavogliflozin versus dapagliflozin as an add-on to metformin in patients with type 2 diabetes mellitus: ENHANCE-M extension study

Tae Seo Sohn, Kyung Ah Han, Yonghyun Kim, Byung Wan Lee, Suk Chon, In Kyung Jeong, Eun Gyoung Hong, Jang Won Son, Jae Jin Na, Jae Min Cho, Seong In Cho, Wan Huh, Kun Ho Yoon

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A 52-week efficacy and safety study of enavogliflozin versus dapagliflozin as an add-on to metformin in patients with type 2 diabetes mellitus: ENHANCE-M extension study'. Together they form a unique fingerprint.

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science